Epigenetic Alteration of Receptor Tyrosine Kinases in Cancer

QR Code

Epigenetic Alteration of Receptor Tyrosine Kinases in Cancer

None

Saved in:

Bibliographic Details
Main Authors:	Dricu, Anica, Purcaru, Stefana Oana, Budiu, Raluca, Ola, Roxana, Tache, Daniela Elise, Vlad, Anda
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Life Sciences
Online Access:	https://www.intechopen.com/chapters/32810
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Signaling of Receptor Tyrosine Kinases in the Nucleus
by: Stephenson, Sally-Anne, et al.
Published: (2012)

The Crucial Role of c-Src Tyrosine Kinase in Bone Metabolism
by: Peruzzi, Barbara, et al.
Published: (2012)

Mechanism of immune escape mediated by receptor tyrosine kinase KIT in thyroid cancer
by: Zhen Luo, et al.
Published: (2023-07-01)

Reversible Inhibition of Tyrosine Protein Phosphatases by Redox Reactions
by: Cosentino-Gomes, Daniela, et al.
Published: (2012)

Spleen Tyrosine Kinase: A Novel Target in Autoimmunity
by: McAdoo, Stephen P., et al.
Published: (2012)

Protein Kinases in Spinal Plasticity: A Role for Metabotropic Glutamate Receptors
by: Huie, J. Russell, et al.
Published: (2012)

NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer
by: Behrad Darvishi, et al.
Published: (2017-06-01)

Regulation of Tyrosine Kinase Signaling by Cbl in Hematopoietic Stem Cells
by: Naramura, Mayumi
Published: (2012)

FLT3 tyrosine kinase in acute non-lymphoblastic leukemias
by: A. S. Bavykin, et al.
Published: (2022-11-01)

Establishment of in vitro Src tyrosine kinase inhibitors screening model
by: WANG Chen-hui, et al.
Published: (2007-11-01)

Dose Optimization of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
by: Chen J, et al.
Published: (2025-07-01)

A live-cell biosensor of in vivo receptor tyrosine kinase activity reveals feedback regulation of a developmental gradient
by: Emily K. Ho, et al.
Published: (2025-07-01)

Ectopic repression of receptor tyrosine kinase–like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial–mesenchymal transition
by: Ying Xu, et al.
Published: (2017-04-01)

Myeloid and Lymphoid Malignancies with Fusion Kinases Involving Spleen Tyrosine Kinase (SYK)—Emerging Rare Entities?
by: Velizar Shivarov, et al.
Published: (2025-06-01)

Epigenetics of the Synaptonemal Complex
by: Hernández-Hernández, Abrahan, et al.
Published: (2012)

Epigenetic Alterations in Cancer: The Therapeutic Potential of Epigenetic Drugs in Cancer Therapy
by: Preeti Gupta
Published: (2025-04-01)

Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
by: Yaqi Zhou, et al.
Published: (2023-07-01)

Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor After Imatinib Resistance
by: Xian-Hao Xiao, et al.
Published: (2025-07-01)

Bruton’s Tyrosine Kinase: A Double-Edged Sword in Cancer and Aging
by: Zahraa Qusairy, et al.
Published: (2025-05-01)

Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review)
by: O.M. Smorodska, et al.
Published: (2021-06-01)

Anticancer activity of tyrosine kinase TrkA receptors antagonist GK-1 in experiment on mice with mammary gland adenocarcinoma Ca755
by: L. P. Kovalenko, et al.
Published: (2024-11-01)

Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer
by: Shaohua Cui, et al.
Published: (2017-04-01)

Molecular genetics monitoring of tyrosine kinase inhibitor therapy for chronic myeloid leukemia
by: S. I. Kutsev, et al.
Published: (2022-11-01)

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients
by: V. A. Shuvaev, et al.
Published: (2014-07-01)

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients
by: Anastasia Putri, et al.
Published: (2020-02-01)

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients
by: Anastasia Putri, et al.
Published: (2020-02-01)

The Mechanisms of Resistance to Tyrosine Kinase Inhibitor Imatinib Therapy of Chronic Myeloid Leukemia
by: S. I. Kutsev, et al.
Published: (2010-06-01)

Innovative Approaches in Cancer Treatment: Emphasizing the Role of Nanomaterials in Tyrosine Kinase Inhibition
by: Antónia Kurillová, et al.
Published: (2025-06-01)

Protein Kinases and Pain
by: Funez, Mani Indiana, et al.
Published: (2012)

Risks of proteinuria associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a systematic review and meta-analysis.
by: Ze-Feng Zhang, et al.
Published: (2014-01-01)

Study of the interaction of the GSB-106 BDNF neurotrophin dipeptide mimetic with the TrkB tyrosine kinase receptor using surface plasmon resonance technology
by: A. V. Tarasiuk, et al.
Published: (2023-01-01)

Long-term endocrine outcomes and quality of life in paediatric and young chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy: a prospective study from India
by: Rajiv Mohan, et al.
Published: (2025-07-01)

Expression of arginase 1 and tyrosine kinase Mer by blood monocytes in the dynamics of physiological pregnancy
by: E. Ya. Shevela, et al.
Published: (2023-06-01)

Second Line Therapies After Tyrosine Kinase Inhibitory in Metastatic Renal Cell Carcinoma
by: Ender DOĞAN, et al.
Published: (2025-04-01)

THE HISTORY OF CHRONIC MYELOID LEUKEMIA (CML): FROM ARSENIC TO TYROSINE KINASE INHIBITORS (TKI)
by: Rüdiger Hehlmann
Published: (2025-07-01)

Site-Directed Mutagenesis in the Research of Protein Kinases - The Case of Protein Kinase CK2
by: Sajnaga, Ewa, et al.
Published: (2013)

Epigenetics in Cancer: The Myelodysplastic Syndrome as a Model to Study Epigenetic Alterations as Diagnostic and Prognostic Biomarkers
by: Fernandez, Teresa de Souza, et al.
Published: (2012)

Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma.
by: Ofir Griess, et al.
Published: (2025-06-01)

Phytochemicals and Cancer Chemoprevention: Epigenetic Friends or Foe?
by: Szic, Katarzyna Szarc vel, et al.
Published: (2011)

Propagating Epigenetic States During DNA Replication
by: Jacobi, Jennifer L., et al.
Published: (2011)